July 4, 2005
Keiji Nakamura, Ph. D. Pharma-Forum Institute, Kamakura, Japan New antidiabetic candidates with a new mode of action under development Upon ingestion of food, the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are synthesised and secreted by gut...read more